The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-(4-(6-(6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-ylamino)pyridin-3-yl)piperazin-1-yl)-N-(2-(2-(cyanomethylamino)ethoxy)ethyl)propanamide ID: ALA4866629
PubChem CID: 164624590
Max Phase: Preclinical
Molecular Formula: C33H44N10O4
Molecular Weight: 644.78
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCN(CCC(=O)NCCOCCNCC#N)CC4)cn3)nc2n(C2CCCC2)c1=O
Standard InChI: InChI=1S/C33H44N10O4/c1-23-27-22-38-33(40-31(27)43(25-5-3-4-6-25)32(46)30(23)24(2)44)39-28-8-7-26(21-37-28)42-17-15-41(16-18-42)14-9-29(45)36-13-20-47-19-12-35-11-10-34/h7-8,21-22,25,35H,3-6,9,11-20H2,1-2H3,(H,36,45)(H,37,38,39,40)
Standard InChI Key: RZGXRZBBJHTULV-UHFFFAOYSA-N
Molfile:
RDKit 2D
47 51 0 0 0 0 0 0 0 0999 V2000
3.8837 -27.3800 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8837 -28.1972 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5890 -28.6017 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.5890 -26.9673 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2943 -27.3800 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2927 -28.1954 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9969 -28.6027 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.7032 -28.1957 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7008 -27.3772 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.9960 -26.9736 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1766 -28.6068 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.5890 -26.1501 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1748 -26.9735 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1724 -26.1563 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.4683 -27.3842 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5935 -29.4220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9331 -29.9034 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1868 -30.6802 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0040 -30.6790 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2553 -29.9014 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4113 -28.6036 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.1186 -28.1943 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8250 -28.6048 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5319 -28.1962 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5315 -27.3781 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8184 -26.9704 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1145 -27.3814 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.2382 -26.9679 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.9469 -27.3748 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2363 -26.1507 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9431 -25.7405 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6517 -26.1474 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.3585 -25.7372 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6536 -26.9646 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0672 -26.1441 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7739 -25.7339 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4826 -26.1408 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.7720 -24.9167 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.1893 -25.7306 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8980 -26.1375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6047 -25.7273 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.3134 -26.1342 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0201 -25.7239 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7288 -26.1309 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.4356 -25.7206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1442 -26.1276 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8509 -26.5306 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 4 2 0
2 3 1 0
3 6 1 0
5 4 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
2 11 2 0
4 12 1 0
1 13 1 0
13 14 2 0
13 15 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 16 1 0
3 16 1 0
8 21 1 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 22 1 0
25 28 1 0
28 29 1 0
28 30 1 0
30 31 1 0
29 34 1 0
31 32 1 0
32 33 1 0
32 34 1 0
33 35 1 0
35 36 1 0
36 37 1 0
36 38 2 0
37 39 1 0
39 40 1 0
40 41 1 0
41 42 1 0
42 43 1 0
43 44 1 0
44 45 1 0
45 46 1 0
46 47 3 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 644.78Molecular Weight (Monoisotopic): 644.3547AlogP: 2.31#Rotatable Bonds: 15Polar Surface Area: 170.40Molecular Species: NEUTRALHBA: 13HBD: 3#RO5 Violations: 2HBA (Lipinski): 14HBD (Lipinski): 3#RO5 Violations (Lipinski): 2CX Acidic pKa: 11.34CX Basic pKa: 7.87CX LogP: 1.41CX LogD: 0.81Aromatic Rings: 3Heavy Atoms: 47QED Weighted: 0.13Np Likeness Score: -1.41
References 1. Shan H, Ma X, Yan G, Luo M, Zhong X, Lan S, Yang J, Liu Y, Pu C, Tong Y, Li R.. (2021) Discovery of a novel covalent CDK4/6 inhibitor based on palbociclib scaffold., 219 [PMID:33857728 ] [10.1016/j.ejmech.2021.113432 ]